The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories

. 2021 Feb 5;19(1):40. doi: 10.1186/s12916-020-01872-8.

See https://pubmed.ncbi.nlm.nih.gov/33323424/

Abstract

Background: Non-pharmaceutical interventions (NPIs) are used to reduce transmission of SARS coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19). However, empirical evidence of the effectiveness of specific NPIs has been inconsistent. We assessed the effectiveness of NPIs around internal containment and closure, international travel restrictions, economic measures, and health system actions on SARS-CoV-2 transmission in 130 countries and territories.

Methods: We used panel (longitudinal) regression to estimate the effectiveness of 13 categories of NPIs in reducing SARS-CoV-2 transmission using data from January to June 2020. First, we examined the temporal association between NPIs using hierarchical cluster analyses. We then regressed the time-varying reproduction number (Rt) of COVID-19 against different NPIs. We examined different model specifications to account for the temporal lag between NPIs and changes in Rt, levels of NPI intensity, time-varying changes in NPI effect, and variable selection criteria. Results were interpreted taking into account both the range of model specifications and temporal clustering of NPIs.

Results: There was strong evidence for an association between two NPIs (school closure, internal movement restrictions) and reduced Rt. Another three NPIs (workplace closure, income support, and debt/contract relief) had strong evidence of effectiveness when ignoring their level of intensity, while two NPIs (public events cancellation, restriction on gatherings) had strong evidence of their effectiveness only when evaluating their implementation at maximum capacity (e.g. restrictions on 1000+ people gathering were not effective, restrictions on < 10 people gathering were). Evidence about the effectiveness of the remaining NPIs (stay-at-home requirements, public information campaigns, public transport closure, international travel controls, testing, contact tracing) was inconsistent and inconclusive. We found temporal clustering between many of the NPIs. Effect sizes varied depending on whether or not we included data after peak NPI intensity.

Conclusion: Understanding the impact that specific NPIs have had on SARS-CoV-2 transmission is complicated by temporal clustering, time-dependent variation in effects, and differences in NPI intensity. However, the effectiveness of school closure and internal movement restrictions appears robust across different model specifications, with some evidence that other NPIs may also be effective under particular conditions. This provides empirical evidence for the potential effectiveness of many, although not all, actions policy-makers are taking to respond to the COVID-19 pandemic.


Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2


John T. Brooks, MD1; Jay C. Butler, MD1
Author Affiliations Article Information
JAMA. 2021;325(10):998-999. doi:10.1001/jama.2021.1505
COVID-19 Resource Center

See https://jamanetwork.com/journals/jama/fullarticle/2776536


Prior to the coronavirus disease 2019 (COVID-19) pandemic, the efficacy of community mask wearing to reduce the spread of respiratory infections was controversial because there were no solid relevant data to support their use. During the pandemic, the scientific evidence has increased. Compelling data now demonstrate that community mask wearing is an effective nonpharmacologic intervention to reduce the spread of this infection, especially as source control to prevent spread from infected persons, but also as protection to reduce wearers’ exposure to infection.

COVID-19 spreads primarily through respiratory droplets exhaled when infected people breathe, talk, cough, sneeze, or sing. Most of these droplets are smaller than 10 μm in diameter, often referred to as aerosols. The amount of small droplets and particles increases with the rate and force of airflow during exhalation (eg, shouting, vigorous exercise). Exposure is greater the closer a person is to the source of exhalations. Larger droplets fall out of the air rapidly, but small droplets and the dried particles formed from them (ie, droplet nuclei) can remain suspended in the air. In circumstances with poor ventilation, typically indoor enclosed spaces where an infected person is present for an extended period, the concentrations of these small droplets and particles can build sufficiently to transmit infection.

Community mask wearing substantially reduces transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2 ways. First, masks prevent infected persons from exposing others to SARS-CoV-2 by blocking exhalation of virus-containing droplets into the air (termed source control). This aspect of mask wearing is especially important because it is estimated that at least 50% or more of transmissions are from persons who never develop symptoms or those who are in the presymptomatic phase of COVID-19 illness.1 In recent laboratory experiments, multilayer cloth masks were more effective than single-layer masks, blocking as much as 50% to 70% of exhaled small droplets and particles.2,3 In some cases, cloth masks have performed similar to surgical or procedure masks for source control. Second, masks protect uninfected wearers. Masks form a barrier to large respiratory droplets that could land on exposed mucous membranes of the eye, nose, and mouth. Masks can also partially filter out small droplets and particles from inhaled air. Multiple layers of fabric and fabrics with higher thread counts improve filtration. However, the observed effectiveness of cloth masks to protect the wearer is lower than their effectiveness for source control,3 and the filtration capacity of cloth masks can be highly dependent on design, fit, and materials used. Standards for cloth masks are needed to help consumers select marketed products.

Epidemiological investigations have helped quantify the benefit of mask wearing to prevent the spread of SARS-CoV-2 (Table; Supplement). At a hair salon in which all staff and clients were required to wear a mask under local ordinance and company policy, 2 symptomatic, infected stylists attended to 139 clients and no infections were observed in the 67 clients who were reached for interviewing and testing. During a COVID-19 outbreak on the USS Theodore Roosevelt, persons who wore masks experienced a 70% lower risk of testing positive for SARS-CoV-2 infection.4 Similar reductions have been reported in case contact investigations when contacts were masked5 and in household clusters in which household members were masked.6

Table.  Studies of the Effect of Mask Wearing on SARS-CoV-2 Infection Riska



An increasing number of ecological studies have also provided persuasive evidence that universal mandatory mask wearing policies have been associated with reductions in the number or rate of infections and deaths (Table). These studies did not distinguish the types of masks (cloth, surgical, or N95) used in the community. This association is strengthened because, in many cases, other mitigation strategies (eg, school and workplace closures, recommendations for social distancing, hand hygiene) had already been deployed before enactment of mask wearing policies, after which the reductions were observed. A study that examined changes in growth rates for infections in 15 states and the District of Columbia before and after mask mandates showed that rates were growing before the mandates were enacted and slowed significantly after, with greater benefit the longer the mandates had been in place.7

Wearing a mask can become uncomfortable, particularly for long periods in warm environments, and covering the nose and mouth may inhibit verbal and nonverbal communication, particularly for children and deaf individuals. However, children aged 7 to 13 years have been shown to be able to make accurate inferences about the emotions of others with partially covered faces,8 and the US Food and Drug Administration recently approved a transparent surgical mask that may be useful in such circumstances. Concerns about reduced oxygen saturation and carbon dioxide retention when wearing a mask have not been supported by available data.9

The overall community benefit of wearing masks derives from their combined ability to limit both exhalation and inhalation of infectious virus. Similar to the principle of herd immunity for vaccination, the greater the extent to which the intervention—mask wearing in this case—is adopted by the community, the larger the benefit to each individual member. The prevalence of mask use in the community may be of greater importance than the type of mask worn. It merits noting that a recent study has been improperly characterized by some sources as showing that cloth or surgical masks offer no benefit. This randomized trial in Denmark was designed to detect at least a 50% reduction in risk for persons wearing surgical masks. Findings were inconclusive,10 most likely because the actual reduction in exposure these masks provided for the wearer was lower. More importantly, the study was far too small (ie, enrolled about 0.1% of the population) to assess the community benefit achieved when wearer protection is combined with reduced source transmission from mask wearers to others.

During past national crises, persons in the US have willingly united and endured temporary sacrifices for the common good. Recovery of the nation from the COVID-19 pandemic requires the combined efforts of families, friends, and neighbors working together in unified public health action. When masks are worn and combined with other recommended mitigation measures, they protect not only the wearer but also the greater community. Recommendations for masks will likely change as more is learned about various mask types and as the pandemic evolves. With the emergence of more transmissible SARS-CoV-2 variants, it is even more important to adopt widespread mask wearing as well as to redouble efforts with use of all other nonpharmaceutical prevention measures until effective levels of vaccination are achieved nationally.

  • No labels